Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators
- PMID: 20304841
- DOI: 10.1093/europace/euq073
Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators
Abstract
The transvenous implantable cardioverter defibrillator (ICD) has emerged as the primary therapy for patients at high risk of life-threatening ventricular arrhythmias. A high number of ICD recipients will require subsequent adjunctive treatment with antiarrhythmic drugs (AADs). This review provides an overview of potential reasons for AAD initiation, candidates for treatment, current medical options, and possible drug-device interactions.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
